Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks

Wen-Fa Zhang1, Preyesh Stephen1,2, Jean-François Thériault1

  • 1Axe Molecular Endocrinology and Nephrology, CHU Research Center and Laval University, Québec City, Québec G1 V 4G2, Canada.

Insights

Understanding SARS-CoV-2 RNA-dependent-RNA-polymerase (RdRp) is crucial for combating the pandemic. This study models SARS-CoV-2 RdRp and shows how inhibitors like Galidesivir bind, aiding drug development.

Area of Science:

  • Virology
  • Structural Biology
  • Drug Discovery

Background:

  • Coronaviruses (CoVs), including SARS-CoV-2, pose a continuous global health threat due to their high contagiousness.
  • RNA-dependent-RNA-polymerase (RdRp) is essential for viral replication, making it a key target for antiviral therapies.
  • SARS-CoV-2 RdRp and NiRAN show high sequence identity (98.1% and 93.2%) with SARS-CoV, suggesting conserved structural and functional properties.

Purpose of the Study:

  • To generate a 3D structural model of SARS-CoV-2 RdRp, NiRAN, nsp7, and nsp8.
  • To investigate the binding interactions of known RdRp inhibitors (Galidesivir, Favipiravir, Penciclovir) with the SARS-CoV-2 RdRp.
  • To provide insights for structure-based optimization of antiviral drugs against SARS-CoV-2.

Main Methods:

  • Comparative sequence alignment of RdRp and Spike proteins across six coronaviruses.
  • 3D structural modeling of SARS-CoV-2 RdRp, NiRAN, nsp7, and nsp8 based on SARS-CoV structures.
  • Molecular docking simulations to analyze the binding poses and interactions of three antiviral inhibitors.

Main Results:

  • High sequence identity observed between SARS-CoV-2 and SARS-CoV RdRp (98.1%) and NiRAN (93.2%).
  • A 3D structural model of key SARS-CoV-2 replication proteins was successfully generated.
  • Binding poses of Galidesivir, Favipiravir, and Penciclovir were elucidated, demonstrating their potential to inhibit viral RNA replication.

Conclusions:

  • The structural model and inhibitor binding analysis provide a foundation for developing effective SARS-CoV-2 antiviral strategies.
  • The conserved nature of RdRp across coronaviruses highlights its potential as a broad-spectrum antiviral target.
  • Structure-based drug design can be effectively employed to optimize existing inhibitors and discover new ones for SARS-CoV-2.

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
591
Bacterial RNA Polymerase00:43

Bacterial RNA Polymerase

Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.3K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K
Eukaryotic RNA Polymerases00:58

Eukaryotic RNA Polymerases

RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
26.4K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.4K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
547